Submissions from 2022
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis., Stanley Cohan, Ralph H B Benedict, Bruce A C Cree, John DeLuca, Le H Hua, and Jerold Chun
Impact of oral health integration training on children's receipt of oral assessment, fluoride varnish and dental services., Hannah Cohen-Cline, Jannate Ahmed, Megan Holtorf, Laura McKeane, and Sarah Bartelmann
Local Housing Choice Voucher Distribution Policies Impact Healthcare Utilization: a Randomized Natural Experiment., Hannah Cohen-Cline, Kyle G Jones, and Keri B Vartanian
CT243 / 4 - Phase 1 study of TAK-676 + pembrolizumab following radiation therapy in patients with advanced non-small-cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), or squamous-cell carcinoma of the head and neck (SCCHN), Benjamin Cooper, David B Page, and See full list of authors in comments
TAK-676 in combination with pembrolizumab after radiation therapy in patients (pts) with advanced non–small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), or squamous-cell carcinoma of the head and neck (SCCHN): Phase 1 study design., Benjamin T. Cooper and David B Page
Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington., Maria A Corcorran, Jenell Stewart, Kristine Lan, Ayushi Gupta, Sara N Glick, Chetan Seshadri, Kevin J Koomalsingh, Edward F Gibbons, Robert D Harrington, Shireesha Dhanireddy, and H Nina Kim
IVIG Research Project, K Couch and ST Chiu
Automated Staging of Breast Cancer Histopathology Images Using Deep Learning, A Crabtree, N Naik, J Searcy, G Srinivasa, C Bifulco, K Matlock, and B Piening
The Economic Impact of Lower Extremity Peri-Prosthetic Fractures in a Large Hospital System., James P Crutcher, Geoffrey Tompkins, Genevieve Rollier, Katie Sypher, Rebecca Valderrama, and Paul J Duwelius
For Ethical Fundraising from Patients, Respect them as Partners., Brendan Curti
Chapter 72: Cancer of the Skin, Brendan Curti, Sancy Leachman, and Walter Urba
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study., Brendan Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries, Lynn Feun, Kim A Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang, Anlong Li, and Robert H I Andtbacka
Development and validation of a model to calculate anesthetic agent consumption from inspired and end-expired concentrations, minute ventilation, fresh gas flow and dead space ventilation., Louise Cuveele, Jan F A Hendrickx, Andre M De Wolf, Sofie De Cooman, Brian B. Chesebro, Jeffrey Feldman, and Jodi Sherman
Dose escalation of davoceticept, a conditional CD28 costimulator and dual checkpoint inhibitor, in advanced malignancies (NEON-1), Diwakar Davar, Rachel E Sanborn, and See full list of authors in comments
Phase 1 study of SEA-TGT, a human, nonfucosylated monoclonal antibody directed to TIGIT with enhanced immune effector function, in patients with advanced malignancies (SGNTGT-001, trial in progress), D Davar, Rachel E Sanborn, and See full list of authors in comments
Case: Stent Thrombosis – Attacked on All Fronts, C H. Davies
Case: Stent Thrombosis – Attacked on All Fronts, CH Davies
Examining Acute Coronary Syndrome Across Ethnicity, Sex, and Age, Kristofer De Leon and Elizabeth Winokur
Climate Change: A Crisis for Family Medicine Educators., Monica DeMasi, Bhargavi Chekuri, Heather L Paladine, and Tina Kenyon
Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in Patients With a Left Ventricular Assist Device., Ashwat S Dhillon, Brandon Jones, Robert W. Hodson, and Ethan C Korngold
PIVOT IO 001: First disclosure of efficacy and safety of bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) vs NIVO monotherapy in advanced melanoma (MEL), A Diab, Brendan Curti, and See all authors in comments
ASHP Foundation Pharmacy Forecast 2022: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems., Joseph T DiPiro, Jannet M Carmichael, Vivian B Johnson, Monika N Daftary, Leyner Martinez, Michelle D Wiest, Binita Patel, Tom Woller, Elva Van Devender, Rita Shane, and Francesca Cunningham
546 A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer, Mary Disis, Sasha Stanton, and See all authors in comments
Automatic Patient Matching for Genome-Guided Adoptive Cell Immunotherapy Trials at a Large Health System, Alexa K Dowdell, Tucker Bower, Benjamin Cosgrove, Roshanthi Weerasinghe, Ann Vita, Brian D. Piening, Carlo Bifulco, Eric Tran, and Rom Leidner
OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines., Rebekka Duhen, Michael Beymer, Shawn M. Jensen, Srinivas Abbina, Suraj Abraham, Nikita Jain, Anitha Thomas, Andrew J Geall, Hong-Ming Hu, Bernard A Fox, and Andrew D Weinberg
PD-1 and ICOS co-expression identifies tumor-reactive CD4 T cells in human solid tumors., Rebekka Duhen, Olivier Fesneau, Kimberly Samson, Alexandra K Frye, Michael Beymer, Venkatesh Rajamanickam, David Ross, Eric Tran, Brady Bernard, Andrew D Weinberg, and Thomas Duhen
OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV-2 spike protein and RNA vaccinations, R Duhen, Bernard A Fox, Andrew D Weinberg, and See all authors in comments
Aperçu de l’immunothérapie et défis de l’immuno-oncologie, T Duhen
PD-1 and ICOS co-expression identifies tumor-reactive CD4 T cells in human solid tumors, Thomas Duhen
Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis., Odianosen Eigbire-Molen, Daniela Hermelin, and Douglas Blackall
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers., Robert S. Epstein, Roshanthi Weerasinghe, Amy S. Parrish, JoAnn Krenitsky, Rachel E Sanborn, and Tehseen Salimi
T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid Cancer Antigens Calcitonin, CEA, and RET M918T., Timothy A Erickson, Yi-Ping Shih, Joseph Fass, Myungkyu Jang, and Eric Tran
Speaking Up for Patient Safety: Will Nurses Report Errors Now a Nurse Has Been Convicted of a Criminal Act?, Cyndi Evans, Jovie Jabla, Geary A Gardner, Taranjeet Rathore, and Elizabeth Ann Scruth
Aldosterone Blocking Agent In-Hospital Prescription Based on Implementation of the ACC Patient Navigator Program: Focus MI, C Eza-Nliam, Ty Gluckman, and See all authors in comments
Chapter: High-Sensitivity C-Reactive Protein, David I. Feldman, Roger S. Blumenthal, and Ty J. Gluckman
A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell Carcinoma., Zizhen Feng, Brendan Curti, David I Quinn, John M Strother, Zunqiu Chen, Rebecca Agnor, Tomasz M Beer, and Christopher W Ryan
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)., Robert L Ferris, Yael Flamand, Gregory S Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J Garcia, Christine H Chung, Maura L Gillison, Umamaheswar Duvvuri, Bert W O'Malley, Enver Ozer, Giovana R Thomas, Wayne M Koch, Neil D Gross, Richard Bryan Bell, Nabil F Saba, Miriam Lango, Eduardo Méndez, and Barbara Burtness
A Review of the Clinical and Cost Effectiveness of Intravenous and Intramuscular Pharmacological Treatment on Acute Agitation in Patients Admitted to the Emergency Department, Ryan Ferris and Carol Keller
Identification of a subset of tumor-reactive CD8 TILs expressing NKG2A in HNSCC and CRC., O Fesneau, Thomas Duhen, and See full list of authors in comments
Identification of a subset of tumor-reactive CD8 TIL expressing NKG2A in HNSCC and CRC, O Fesneau, K Samson, V Rajamanickam, D Ross, and Thomas Duhen
Post-Operative Mitral Valve Intervention Hemostasis in Patients that Receive Vitamin K Supplementation, Torin P. Fitton
A Vision for Personalizing Treatments to Overcome Cancer’s Escape Mechanisms and Improve Outcomes for Patients, Bernard Fox
Cancer Vaccines: A Phoenix Rising from the Ashes, Bernard Fox
Combining 10x scRNA-seq and 100 plex mIF: Too much data or complimentary technologies to examine what works, Bernard Fox
Complex Cancer Vaccines: An Approach to Induce Immunity Against Gastroesophageal Malignancies in 2022, Bernard Fox
Comprehensive Spatial Phenotyping: Mapping the Tumor Microenvironment at Scale, Bernard Fox
Immune Activating and Cancer Vaccine Technology, Bernard Fox
Overview of Immunotherapy and Challenges for Immuno-Oncology, Bernard Fox
Recommended phase 2 dose (RP2D) of HB-200 arenavirus-based cancer immunotherapies in patients with HPV16+ cancers., Siqing Fu, Rom Leidner, and Matthew H Taylor
Functional status at 30 and 90 days after mild ischaemic stroke., Hannah Gardener, Leo A Romano, Eric E Smith, Iszet Campo-Bustillo, Yosef Khan, Sofie Tai, Nikesha Riley, Ralph L Sacco, Pooja Khatri, Heather M Alger, Brian Mac Grory, Deepak Gulati, Navdeep S Sangha, Karin E Olds, Curtis G Benesch, Adam G Kelly, Scott S Brehaut, Amit Kansara, Lee H Schwamm, and Jose G Romano
Management of Anorectal Malformations and Hirschsprung Disease., Colin D Gause and Sanjay Krishnaswami
Video game rehabilitation for outpatient stroke (VIGoROUS): A multi-site randomized controlled trial of in-home, self-managed, upper-extremity therapy., Lynne V Gauthier, Deborah S Nichols-Larsen, Gitendra Uswatte, Nancy Strahl, Marie Simeo, Rachel Proffitt, Kristina Kelly, Roger Crawfis, Edward Taub, David Morris, Linda Pax Lowes, Victor Mark, and Alexandra Borstad
A Phase 1 Study of TAK-676, a Novel STING Agonist, Plus Pembrolizumab Following Radiation Therapy in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC), Triple-Negative Breast Cancer (TNBC), or Squamous-Cell Carcinoma of the Head and Neck (SCCHN), NK Gerber, DB Page, and See all authors in comments
A phase 2 study of an off-the-shelf, multi-neoantigen vector (ADXS-503) in patients with metastatic non–small cell lung cancer either progressing on prior pembrolizumab or in the first-line setting., Gregory James Gerstner, Rachel E Sanborn, and See full list of authors in comments
Safety Analyses of NRG BR004: A Randomized, Double-blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-line HER2-Postive Metastatic Breast Cancer (MBC), CE Geyer and DB Page
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Foundation 3504., Maura L Gillison, Robert L Ferris, Jonathan Harris, A Dimitrios Colevas, Loren K Mell, Christina Kong, Richard C Jordan, Kevin L Moore, Minh-Tam Truong, Claudia Kirsch, Arnab Chakravarti, Dukagjin M Blakaj, David A Clump, James P Ohr, John F Deeken, Michael F Gensheimer, Nabil F Saba, Jennifer A Dorth, David I Rosenthal, Rom S Leidner, Randall J Kimple, Mitchell Machtay, Walter J Curran, Pedro Torres-Saavedra, and Quynh Thu Le
Housing and Reentry: A Mixed-Method Evaluation of a Low-Cost Community-Based Intervention for Increasing Access to Housing Post-Incarceration, Monique Gill, Kyle Jones, Ritu Ghosal, James M. Scanlan, and Emily J. Cox
Accelerating Cardiovascular Outcomes/Health Services Research Within Community-Based Health Systems-Lessons Learned and Steps Moving Forward, Ty J. Gluckman
Accelerating Cardiovascular Outcomes/Health Services Research Within Community-Based Health Systems-Lessons Learned and Steps Moving Forward, Ty J. Gluckman
Acute, Near-Term, and Long-Term Cardiovascular Sequelae of COVID-19, Ty J. Gluckman
Benefit and Barriers to New Quality Measures, Ty J. Gluckman
Cardiovascular Sequelae of COVID-19, Ty J. Gluckman
Cardiovascular Sequelae of COVID-19, Ty J. Gluckman
Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis, Long COVID, and Return to Play, Ty J. Gluckman
Cost of Prevention—How Much is Too Much?, Ty J. Gluckman
Diversifying Patients in Clinical Trials--Approaches to Different Trial Designs, Ty J. Gluckman
Intersection of Antiplatelet and Anticoagulant Therapy-What to Do When a Patient Needs Both, Ty J. Gluckman
Ongoing Dilemmas with Surveillance and Diagnosis of Atrial Fibrillation, Ty J. Gluckman
Prevention and Treatment of COVID-19: A Review of the Current Data, Ty J. Gluckman
Referral to Advanced Heart Failure-A Key Component in Team-Based Care, Ty J. Gluckman
Target: Aortic Stenosis—Initiative Experience, Ty J. Gluckman
Treadmill, Nuclear Myocardial Perfusion Imaging (MPI), and Cardiac PET, Ty J. Gluckman
Stakeholder Perspectives - Clinical Care, Ty J. Gluckman, J Bachmann, H Chetan, ATS Sandhu, and C Porter
Accelerating Cardiovascular Outcomes/Health Services Research Within Community-Based Health Systems-Lessons Learned and Steps Moving Forward, Tyler J Gluckman
Accelerating Cardiovascular Outcomes/Health Services Research Within Community-Based Health Systems-Lessons Learned and Steps Moving Forward, Tyler J Gluckman
Accelerating Cardiovascular Outcomes/Health Services Research Within Community-Based Health Systems-Lessons Learned and Steps Moving Forward, Tyler J Gluckman
Cardiovascular Sequelae of COVID-19, Tyler J Gluckman
Cost of Prevention—How Much is Too much?, Tyler J Gluckman
Do Registries Help Us or Cost Us, Tyler J Gluckman
Incorporating the 2021 AHA/ACC Chest Pain Guidelines Into My Clinical Practice, Tyler J Gluckman
Optimizing LDL-C: Individualizing Treatment Using Statins and Nonstatin Therapy, Tyler J Gluckman
Prevention and Treatment of COVID-19: A Review of the Current Data, Tyler J Gluckman
Treadmill, Nuclear Myocardial Perfusion Imaging (MPI), and Cardiac PET, Tyler J Gluckman
ACC Expert Consensus Decision Pathway of Bleeding Management in Patients on Oral Anticoagulant and Cost Implications, Tyler J Gluckman and See full list of authors in comments
Polyunsaturated fatty acids, omega-3 fatty acids, and eicosapentaenoic acid- mechanisms of action, Tyler J Gluckman and See full list of authors in comments
A phase 1b, multicenter, dose-escalation study of subasumstat (TAK-981) in combination with pembrolizumab in patients (pts) with advanced solid tumors., Sanjay Goel, Rachel E Sanborn, and See full list of authors in comments
Safety and tolerability of MEDI0562, an OX40 agonist monoclonal antibody, in combination with durvalumab or tremelimumab in adult patients with advanced solid tumors., Jonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, Katrina S Pedersen, Todd M Bauer, Stefanie L Groenland, Richard D Carvajal, Vaishali Chhaya, Gray Kirby, Kelly McGlinchey, Scott A Hammond, Katie L Streicher, Danielle Townsley, Young Kwang Chae, Jens Voortman, Aurelien Marabelle, and John Powderly
The Development and Dynamics of Pre-existing immunity in tumors, Michael Gough
Fluorescence tagging to monitor CD8 T cell recirculation from the tumor to the tumor-draining lymph node: the impact of focal radiation therapy on recirculation, Michael J. Gough
Tumor resident memory CD8 T cell formation and concomitant tumor immunity is CD40L dependent and CD4 independent, Michael J. Gough
The paradox of radiation and T cells in tumors., Michael J. Gough and Marka R Crittenden
Tumor resident memory CD8 T cell formation and concomitant tumor immunity is CD40L dependent and CD4 independent., Michael J. Gough, Thomas Duhen, Marka R Crittenden, and See all authors in comments
Differences in access to virtual and in-person primary care by race/ethnicity and community social vulnerability among adults diagnosed with COVID-19 in a large, multi-state health system., Diana J Govier, Hannah Cohen-Cline, Katherine Marsi, and Sarah E Roth
Leveraging Healthcare System Data to Identify High-Risk Dyslipidemia Patients., Nayrana Griffith, Grace Bigham, Aparna Sajja, and Ty J Gluckman
Reproductive Health Features Associated with SCAD: A Report of the iSCAD Registry, A Grodzinsky, L Tam, and See all authors in comments
